MedPath

A randomised controlled trial of oxytocin 5 IU versus oxytocin 5 IU and 30 IU infusion for the control of blood loss at elective caesarean section - pilot study. - caesarean third stage trial

Phase 1
Conditions
Elective lower segment caesarean section
Registration Number
EUCTR2005-001361-34-GB
Lead Sponsor
niversity of Dundee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Female
Target Recruitment
75
Inclusion Criteria

Healthy women at term (> 36 weeks) with a singleton pregnancy booked for an elective caesarean section
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

placenta praevia; multiple pregnancy; known coagulopathy; current anti-coagulant therapy; thrombocytopenia

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath